Skip to content
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
IFPMA
  • Who We Are
    • IFPMA in Brief
    • Our Governance and Leadership
    • Our Membership
      • Full Members
        • Associations
        • Companies
      • Associate Members
      • Affiliate Members
    • Our Experts
    • Join Us
  • Topics
  • News Center
    • News Releases
    • Blog
      • Global Health Matters
      • Science Matters
      • Contributors
    • Statements
    • Latest News from Our Members
  • Resources
    • Publications
      • News Releases
      • Statements
      • Position Papers
      • Publications
      • External Studies
      • Infographics
      • Event Highlights
    • Multimedia
      • Interviews
      • Podcasts
      • Videos
      • Photos
      • Slides
    • IFPMA Interactive Platforms
      • Health Partnerships Directory
      • Our Engagement on NCD
      • Pharma by Numbers
    • 50 Years of Global Health Progress
  • Events
    • Upcoming IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
    • Past IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
  • Partners
  • Discovering medicines and Vaccines
  • Strengthening Regulatory Systems
  • Building trust
  • Boosting Innovation and Access
  • Tackling Global health challenges
Economic footprint IP Pharma by numbers Sustainable innovation Value of innovation

spotlight

Value of innovation

Discovering medicines and Vaccines
Biosimilars Biotherapeutic medicines Falsified medicines Import testing Pharma by numbers Pharmacovigiliance Quality, safety, and efficacy Regulatory conferences Regulatory system strengthening / Harmonization Supply chain The Africa Regulatory Network (ARN) The ARN: Le réseau africain de réglementation pharmaceutique

spotlight

Pharmacovigiliance

Strengthening Regulatory Systems
New IFPMA Code of Practice (2019) IFPMA Code of Practice 2019 - Our Ethos Code training Code of practice operating procedure Code of practice: how to file a complaint? Complaint submission form Cases Consensus framework for ethical collaboration

spotlight

New IFPMA Code of Practice (2019)

Building trust
Access to medicines Health technology assessment IP Pharma by numbers Trade

spotlight

Access to medicines

Boosting Innovation and Access
Ageing Antimicrobial resistance Cancer Child and maternal health Diabetes Do you mind? campaign Ebola Falsified medicines Health partnerships HIV/AIDS Humanitarian and disaster relief aid Influenza vaccine Malaria Mental and neurological disorders Neglected tropical diseases Non-communicable diseases Pandemic influenza preparedness Pharma by numbers Psoriasis Rare diseases Seasonal influenza Supply chain Sustainable development goals Tuberculosis Universal health coverage Vaccines innovation Vaccines protect communities Vaccines sustainability Value of immunization Viral hepatitis Workplace wellness Zika Virus

spotlight

Universal health coverage

Tackling Global health challenges
  • Home
  • >
  • Resources
  • >
  • External Studies
  • >
  • Counterfeit drug penetration into global legitimate medicine supply chains: A global assessment

Counterfeit drug penetration into global legitimate medicine supply chains: A global assessment

Published on: 20 April 2015

Cover_Counterfeit_Drug_Penetration

Download

» AJTMH_Counterfeit Drug Penetration into Global Legitimate Medicine Supply Chains_April2015

Resources

1. Counterfeit medicines in legitimate supply chains, A study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)
Infographics

Infographics

1. Counterfeit medicines in legitimate supply chains, A study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)

World Health Assembly on counterfeits
Statements

Statements

World Health Assembly on counterfeits

Counterfeit medicines in legitimate supply chains SDCP & PSI Study
Infographics

Infographics

Counterfeit medicines in legitimate supply chains SDCP & PSI Study

Global pharmaceutical associations welcome MEDICRIME convention, landmark tool to curb global medicines counterfeiting
News Releases

News Releases

Global pharmaceutical associations welcome MEDICRIME convention, landmark tool to curb global medicines counterfeiting

IFPMA’s 10 principles on counterfeit medicines
Infographics

Infographics

IFPMA’s 10 principles on counterfeit medicines

WHA 68, Item 17.3, Substandard/spurious/falsely-labelled/falsified/counterfeit medical products
Statements

Statements

WHA 68, Item 17.3, Substandard/spurious/falsely-labelled/falsified/counterfeit medical products

Related Blog Entries

Making Progress in Fighting Counterfeit Drugs in Africa

Making Progress in Fighting Counterfeit Drugs in Africa

Traffic in Counterfeit Medicines Must be Curbed through International Cooperation and Regulatory Harmonization

Traffic in Counterfeit Medicines Must be Curbed through International Cooperation and Regulatory Harmonization

Related Topics

Supply chain
Falsified medicines

Tags

  • Counterfeit Medicines
  • Counterfeiting
  • Counterfeits
  • Global systems
  • Supply Chains
IFPMA

Chemin des Mines 9
P.O. BOX 195
1211 Geneva 20
Switzerland

+41 22 338 32 00
info@ifpma.org

  • Careers
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Access to Our Extranet
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
Designed and Produced by ACW ^ Back to Top
Cookie Policy
This website uses cookies to ensure you get the best experience on our website. Learn More
Decline Allow Cookies